NO20010882D0 - Terapier for behandling av lungesykdommer - Google Patents

Terapier for behandling av lungesykdommer

Info

Publication number
NO20010882D0
NO20010882D0 NO20010882A NO20010882A NO20010882D0 NO 20010882 D0 NO20010882 D0 NO 20010882D0 NO 20010882 A NO20010882 A NO 20010882A NO 20010882 A NO20010882 A NO 20010882A NO 20010882 D0 NO20010882 D0 NO 20010882D0
Authority
NO
Norway
Prior art keywords
therapies
treatment
lung diseases
lung
diseases
Prior art date
Application number
NO20010882A
Other languages
English (en)
Norwegian (no)
Other versions
NO20010882L (no
Inventor
Richard Nieman
Anthony S Rebuck
Theodore J Torphy
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20010882D0 publication Critical patent/NO20010882D0/no
Publication of NO20010882L publication Critical patent/NO20010882L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20010882A 1998-08-26 2001-02-21 Terapier for behandling av lungesykdommer NO20010882L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9797398P 1998-08-26 1998-08-26
PCT/US1999/019332 WO2000012078A1 (en) 1998-08-26 1999-08-24 Therapies for treating pulmonary diseases

Publications (2)

Publication Number Publication Date
NO20010882D0 true NO20010882D0 (no) 2001-02-21
NO20010882L NO20010882L (no) 2001-02-21

Family

ID=22266001

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010882A NO20010882L (no) 1998-08-26 2001-02-21 Terapier for behandling av lungesykdommer

Country Status (21)

Country Link
US (2) US6288118B1 (hu)
EP (1) EP1107747A4 (hu)
JP (1) JP2002523452A (hu)
KR (1) KR20010072931A (hu)
CN (1) CN1314811A (hu)
AR (1) AR022072A1 (hu)
AU (1) AU754379B2 (hu)
BR (1) BR9913152A (hu)
CA (1) CA2341488A1 (hu)
CZ (1) CZ293735B6 (hu)
DZ (1) DZ2876A1 (hu)
HU (1) HUP0103160A3 (hu)
IL (1) IL141335A0 (hu)
MA (1) MA26302A1 (hu)
MY (1) MY126544A (hu)
NO (1) NO20010882L (hu)
NZ (1) NZ527232A (hu)
PE (1) PE20001032A1 (hu)
PL (1) PL346271A1 (hu)
TR (1) TR200100500T2 (hu)
WO (1) WO2000012078A1 (hu)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6525018B1 (en) * 1999-05-17 2003-02-25 The General Hospital Corp. Treating eye disorders using intestinal trefoil proteins
US6624181B1 (en) 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
US20030186882A1 (en) * 2001-07-31 2003-10-02 Podolsky Daniel K. Methods and compositions for treating and preventing distal bowel lesions
US20030185838A1 (en) * 2001-11-28 2003-10-02 Podolsky Daniel K. Methods and compositions for treating lesions of the respiratory epithelium
TR200100500T2 (tr) * 1998-08-26 2001-06-21 Smithkline Beecham Corporation Pulmoner hastalıkların tedavisi için terapiler
US8933032B2 (en) 1998-10-20 2015-01-13 Children's Hospital Medical Center Surfactant protein D for the treatment of disorders associated with lung injury
SI1212089T1 (sl) * 1999-08-21 2006-08-31 Altana Pharma Ag Sinergisticna kombinacija roflumilasta in salmeterola
EA005824B1 (ru) 2000-06-05 2005-06-30 Алтана Фарма Аг СОЕДИНЕНИЯ, ЭФФЕКТИВНЫЕ В КАЧЕСТВЕ АГОНИСТОВ β-2-АДРЕНОРЕЦЕПТОРА И ИНГИБИТОРОВ ФОСФОДИЭСТЕРАЗЫ PDE4
US20030148949A1 (en) * 2001-10-05 2003-08-07 Podolsky Daniel K. Methods and compositions for treating dermal lesions
US7538082B2 (en) 2001-04-24 2009-05-26 The General Hospital Corporation Methods and compositions for treating oral and esophageal lesions
US20060189526A1 (en) * 2002-04-24 2006-08-24 Podolsky Daniel K Compositions containing an intestinal trefoil peptide and a mucoadhesive
US20030105016A1 (en) * 2001-09-06 2003-06-05 Podolsky Daniel K. Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions
US20040171544A1 (en) * 2001-04-24 2004-09-02 Barker Nicholas P. Trefoil domain-containing polypeptides and uses thereof
US20030181384A1 (en) * 2001-09-06 2003-09-25 Podolsky Daniel K. Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions
US20030185839A1 (en) * 2001-10-05 2003-10-02 Podolsky Daniel K. Methods and compositions for treating dermal lesions
US7931022B2 (en) * 2001-10-19 2011-04-26 Respirks, Inc. Method and apparatus for dispensing inhalator medicament
CN1617739A (zh) * 2001-11-28 2005-05-18 综合医院公司 用于治疗呼吸道上皮病变的方法和组合物
GB0129395D0 (en) * 2001-12-07 2002-01-30 Pfizer Ltd Pharmaceutical combination
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
AU2003224773B2 (en) * 2002-03-26 2010-08-26 The General Hospital Corporation Combination therapy using trefoil peptides
DE10220459A1 (de) * 2002-05-07 2003-11-27 Byk Gulden Lomberg Chem Fab Neue Kombination zur Behandlung von Atemwegserkrankungen
CA2484276A1 (en) * 2002-05-07 2003-11-20 Altana Pharma Ag Combination of a proton pump inhibitor and a respiratory agent for the treatment of respiratory diseases
DE10220458A1 (de) * 2002-05-07 2003-11-27 Altana Pharma Ag Kombination zur Behandlung von Atemwegserkrankungen
JP2005528418A (ja) * 2002-05-07 2005-09-22 アルタナ　ファルマ　アクチエンゲゼルシャフト 気道疾患を治療するための新規組み合わせ
US20060188471A1 (en) * 2002-10-31 2006-08-24 Podolsky Daniel K Methods of treating epithelial lesions
DE60321954D1 (de) * 2002-11-27 2008-08-14 Nycomed Gmbh Synergistische zusammensetzung enthaltend roflumilast und (r,r)-formoterol
PL216752B1 (pl) * 2002-11-27 2014-05-30 Nycomed Gmbh Środek leczniczy do zapobiegania objawom lub do leczenia chorób dróg oddechowych u ludzi i zastosowanie
US7470791B2 (en) 2003-03-10 2008-12-30 Nycomed Gmbh Process for the preparation of roflumilast
JPWO2004087151A1 (ja) * 2003-03-31 2006-06-29 協和醗酵工業株式会社 医薬組成物
SE527200C2 (sv) * 2003-06-19 2006-01-17 Microdrug Ag Inhalatoranordning samt kombinerade doser av formaterol och fluticason
JP2008502699A (ja) * 2004-06-14 2008-01-31 セプラコール・インコーポレイテッド 肺疾患治療方法、及びそのための組成物
EP1773325A4 (en) * 2004-06-14 2007-11-07 Sepracor Inc METHODS OF USING ALBUTEROL AND AGENTS INDUCING THE OPENING OF POTASSIUM CHANNELS ACTIVATED BY CALCIUM
ES2421916T3 (es) 2005-03-16 2013-09-06 Nycomed Gmbh Forma farmacéutica de sabor enmascarado que contiene roflumilast
DE102005030733A1 (de) * 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
US20090182035A1 (en) * 2007-04-11 2009-07-16 Alcon Research, Ltd. Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
JP2010523695A (ja) * 2007-04-11 2010-07-15 アルコン リサーチ， リミテッド アレルギー性鼻炎およびアレルギー性結膜炎を処置するためのＴＮＦαのインヒビターおよび抗ヒスタミン薬の使用
WO2010124058A1 (en) * 2009-04-22 2010-10-28 Indiana University Research And Technology Corporation Compositions for use in the treatment of chronic obstructive pulmonary diseases and asthma
AU2010300421B2 (en) * 2009-10-01 2014-01-23 Alcon Research, Ltd. Olopatadine compositions and uses thereof
KR101035488B1 (ko) * 2009-10-05 2011-05-20 숭실대학교산학협력단 자동차 블랙박스 영상물 수집 방법
WO2011056561A1 (en) 2009-10-27 2011-05-12 Beth Israel Deaconess Medical Center Methods and compositions for the generation and use of conformation-specific antibodies
US8367829B2 (en) 2010-05-10 2013-02-05 Gilead Sciences, Inc. Bi-functional pyrazolopyridine compounds
CA2796826A1 (en) * 2010-05-10 2011-11-17 Gilead Sciences, Inc. Bifunctional quinoline derivatives
WO2012149334A2 (en) 2011-04-27 2012-11-01 Beth Israel Deaconess Medical Center, Inc. Methods and compositions for the generation and use of conformation-specific antibodies
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof
US10433624B2 (en) * 2015-03-26 2019-10-08 Nike, Inc. Duffel bag
WO2019157144A1 (en) 2018-02-07 2019-08-15 Duke University System and method for homogenous gpcr phosphorylation and identification of beta-2 adrenergic receptor positive allosteric modulators

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791025A (fr) 1971-11-19 1973-05-07 Allen & Hanburys Ltd Composes heterocycliques
GB1457873A (en) 1973-01-04 1976-12-08 Allen & Hanburys Ltd Imidazotriazines
FR2390164A1 (fr) 1977-05-13 1978-12-08 Blanie Paul Association a action anti-asthmatique
US5602110A (en) 1994-08-31 1997-02-11 Case Western Reserve University Method and composition for treating cystic fibrosis
FR2753706B1 (fr) * 1996-09-20 1998-10-30 Nouvelles amines cycliques n-substituees, leur procede de preparation et les compositions pharmaceutiques les renfermant
FR2753969B1 (fr) * 1996-09-27 1998-10-30 Adir Nouveaux derives de flavones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ATE386531T1 (de) * 1997-02-28 2008-03-15 Nycomed Gmbh Synergistische kombination von pde-hemmern und adenylatcyclase-agonisten bzw. guanylcyclyse- agonisten
US5858694A (en) 1997-05-30 1999-01-12 Cell Pathways, Inc. Method for identifying compounds for inhibition of cancerous lesions
TR200100500T2 (tr) * 1998-08-26 2001-06-21 Smithkline Beecham Corporation Pulmoner hastalıkların tedavisi için terapiler

Also Published As

Publication number Publication date
US20010056122A1 (en) 2001-12-27
MY126544A (en) 2006-10-31
AR022072A1 (es) 2002-09-04
WO2000012078A1 (en) 2000-03-09
MA26302A1 (fr) 2004-10-01
CA2341488A1 (en) 2000-03-09
NZ527232A (en) 2005-03-24
CZ2001692A3 (cs) 2002-02-13
AU754379B2 (en) 2002-11-14
HUP0103160A2 (hu) 2002-01-28
EP1107747A1 (en) 2001-06-20
PE20001032A1 (es) 2000-11-10
US6555583B2 (en) 2003-04-29
CN1314811A (zh) 2001-09-26
CZ293735B6 (cs) 2004-07-14
US6288118B1 (en) 2001-09-11
JP2002523452A (ja) 2002-07-30
BR9913152A (pt) 2001-05-15
KR20010072931A (ko) 2001-07-31
IL141335A0 (en) 2002-03-10
TR200100500T2 (tr) 2001-06-21
NO20010882L (no) 2001-02-21
HUP0103160A3 (en) 2002-11-28
DZ2876A1 (fr) 2003-12-15
PL346271A1 (en) 2002-01-28
AU5493999A (en) 2000-03-21
EP1107747A4 (en) 2003-04-23

Similar Documents

Publication Publication Date Title
NO20010882D0 (no) Terapier for behandling av lungesykdommer
NO20012995L (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
NO965377L (no) Indolinonforbindelser for behandling av sykdommer
NO995221D0 (no) Sulfonamider for behandling av endotelinmedierte sykdommer
NO20005864D0 (no) Quinasoler til behandling av hjernesvulst
ATE308527T1 (de) Phenylamino-substituierte triicyclische derivate zur behandlung hyperproliferativer krankheiten
NO20005884L (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
NO991381D0 (no) Kombinasjonsterapi for behandling av psykoser
ATE262331T1 (de) Heterocyclische vinylether zur behandlung neurologischer krankheiten
ATE246500T1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen erkrankungen der atemwege
FI971568A (fi) Menetelmä resistenttien kasvainten hoitamiseksi
EE200300214A (et) Sulfoonamiidid endoteliini vahendatud haiguste ravimiseks
NO20005885L (no) Kombinasjonsterapi for behandling av refraktær depresjon
NO990722D0 (no) FremgangsmÕte for behandling av hjertesvikt
GB0004531D0 (en) The treatment of respiratory diseases
EP1039883A4 (en) METHOD FOR TREATING APOLIPOPROTEIN E CONDITIONAL DISEASES
NO973081D0 (no) Fremgangmåte for behandling av kroniske progressive vaskulære sykdommer
NO20020784L (no) Medikament for behandling av brudd
ATE261434T1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
EE03437B1 (et) Benseenamiidid neurodegeneratiivsete haiguste ravimiseks
NO991164D0 (no) Farmas°ytisk preparat for behandling av virussykdommer
NO20003481D0 (no) FremgangsmÕte for behandling av COPD
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
AU3004000A (en) Methods for the treatment of apolipoprotein e related diseases
NO20002481D0 (no) Kombinasjonsterapi for behandling av AIDS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application